Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1996 Jan 15;97(2):455–460. doi: 10.1172/JCI118435

Hyperproinsulinemia is associated with increased beta cell demand after hemipancreatectomy in humans.

E R Seaquist 1, S E Kahn 1, P M Clark 1, C N Hales 1, D Porte Jr 1, R P Robertson 1
PMCID: PMC507037  PMID: 8567967

Abstract

The cause of disproportionate hyperproinsulinemia in patients with type II diabetes is controversial. To examine whether increased beta cell demand might contribute, we measured proinsulin and insulin concentrations in clinically healthy humans who had undergone hemipancreatectomy for the purpose of organ donation, a procedure previously demonstrated to increase beta cell demand and diminish insulin secretory reserve capacity. Subjects were studied at least 1 yr after hemipancreatectomy. Seven donors were followed prospectively and serves as their own controls. Nine additional donors were matched with normal controls (cross-sectional group). Fasting serum concentrations of intact proinsulin and conversion intermediates (total) were measured by a two-step radioimmunoassay; independent determinations of intact proinsulin and 32,33 split proinsulin were performed using an immunoradiometric assay. Serum total proinsulin values were significantly greater in hemipancreatectomized groups than controls (prospective group: predonation = 6.24 +/- 1.14 pM, postdonation = 34.63 +/- 17.47 pM, P < 0.005; cross-sectional group: controls = 5.78 +/- 1.12 pM, donors = 15.22 +/- 5.20 pM, P < 0.025). The ratio of total proinsulin to immunoreactive insulin was directly correlated with fasting plasma glucose and showed a significant inverse relationship to secretory reserve capacity. Both absolute and relative hyperproinsulinemia is found in hemipancreatectomized donors. These data demonstrate that partial pancreatectomy with its associated increase in beta cell demand raises measures of proinsulin in humans.

Full Text

The Full Text of this article is available as a PDF (167.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alarcón C., Leahy J. L., Schuppin G. T., Rhodes C. J. Increased secretory demand rather than a defect in the proinsulin conversion mechanism causes hyperproinsulinemia in a glucose-infusion rat model of non-insulin-dependent diabetes mellitus. J Clin Invest. 1995 Mar;95(3):1032–1039. doi: 10.1172/JCI117748. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Barbosa J., King R., Noreen H., Yunis E. J. The histocompatibility system in juvenile, insulin-dependent diabetic multiplex kindreds. J Clin Invest. 1977 Nov;60(5):989–998. doi: 10.1172/JCI108879. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Beer S. F., O'Rahilly S., Spivey R. S., Hales C. N., Turner R. C. Plasma proinsulin in first-degree relatives of type 2 diabetic subjects. Diabetes Res. 1990 Jun;14(2):51–54. [PubMed] [Google Scholar]
  4. Birkeland K. I., Torjesen P. A., Eriksson J., Vaaler S., Groop L. Hyperproinsulinemia of type II diabetes is not present before the development of hyperglycemia. Diabetes Care. 1994 Nov;17(11):1307–1310. doi: 10.2337/diacare.17.11.1307. [DOI] [PubMed] [Google Scholar]
  5. Duckworth W. C., Kitabchi A. E. Direct measurement of plasma proinsulin in normal and diabetic subjects. Am J Med. 1972 Oct;53(4):418–427. doi: 10.1016/0002-9343(72)90137-4. [DOI] [PubMed] [Google Scholar]
  6. Gorden P., Hendricks C. M., Roth J. Circulating proinsulin-like component in man: increased proportion in hypoinsulinemic states. Diabetologia. 1974 Oct;10(5):469–474. doi: 10.1007/BF01221640. [DOI] [PubMed] [Google Scholar]
  7. Haffner S. M., Bowsher R. R., Mykkänen L., Hazuda H. P., Mitchell B. D., Valdez R. A., Gingerich R., Monterossa A., Stern M. P. Proinsulin and specific insulin concentration in high- and low-risk populations for NIDDM. Diabetes. 1994 Dec;43(12):1490–1493. doi: 10.2337/diab.43.12.1490. [DOI] [PubMed] [Google Scholar]
  8. Halter J. B., Graf R. J., Porte D., Jr Potentiation of insulin secretory responses by plasma glucose levels in man: evidence that hyperglycemia in diabetes compensates for imparied glucose potentiation. J Clin Endocrinol Metab. 1979 Jun;48(6):946–954. doi: 10.1210/jcem-48-6-946. [DOI] [PubMed] [Google Scholar]
  9. Hartling S. G., Lindgren F., Dahlqvist G., Persson B., Binder C. Elevated proinsulin in healthy siblings of IDDM patients independent of HLA identity. Diabetes. 1989 Oct;38(10):1271–1274. doi: 10.2337/diab.38.10.1271. [DOI] [PubMed] [Google Scholar]
  10. Heaton D. A., Millward B. A., Gray I. P., Tun Y., Hales C. N., Pyke D. A., Leslie R. D. Increased proinsulin levels as an early indicator of B-cell dysfunction in non-diabetic twins of type 1 (insulin-dependent) diabetic patients. Diabetologia. 1988 Mar;31(3):182–184. doi: 10.1007/BF00276853. [DOI] [PubMed] [Google Scholar]
  11. Kahn S. E., Beard J. C., Schwartz M. W., Ward W. K., Ding H. L., Bergman R. N., Taborsky G. J., Jr, Porte D., Jr Increased beta-cell secretory capacity as mechanism for islet adaptation to nicotinic acid-induced insulin resistance. Diabetes. 1989 May;38(5):562–568. doi: 10.2337/diab.38.5.562. [DOI] [PubMed] [Google Scholar]
  12. Kahn S. E., Horber F. F., Prigeon R. L., Haymond M. W., Porte D., Jr Effect of glucocorticoid and growth hormone treatment on proinsulin levels in humans. Diabetes. 1993 Jul;42(7):1082–1085. doi: 10.2337/diab.42.7.1082. [DOI] [PubMed] [Google Scholar]
  13. Kahn S. E., Leonetti D. L., Prigeon R. L., Boyko E. J., Bergstrom R. W., Fujimoto W. Y. Proinsulin as a marker for the development of NIDDM in Japanese-American men. Diabetes. 1995 Feb;44(2):173–179. doi: 10.2337/diab.44.2.173. [DOI] [PubMed] [Google Scholar]
  14. Kendall D. M., Sutherland D. E., Najarian J. S., Goetz F. C., Robertson R. P. Effects of hemipancreatectomy on insulin secretion and glucose tolerance in healthy humans. N Engl J Med. 1990 Mar 29;322(13):898–903. doi: 10.1056/NEJM199003293221305. [DOI] [PubMed] [Google Scholar]
  15. Lindgren F. A., Hartling S. G., Dahlquist G. G., Binder C., Efendić S., Persson B. E. Glucose-induced insulin response is reduced and proinsulin response increased in healthy siblings of type 1 diabetic patients. Diabet Med. 1991 Aug-Sep;8(7):638–643. doi: 10.1111/j.1464-5491.1991.tb01670.x. [DOI] [PubMed] [Google Scholar]
  16. Neufeld M., Maclaren N. K., Riley W. J., Lezotte D., McLaughlin J. V., Silverstein J., Rosenbloom A. L. Islet cell and other organ-specific antibodies in U.S. Caucasians and Blacks with insulin-dependent diabetes mellitus. Diabetes. 1980 Aug;29(8):589–592. doi: 10.2337/diab.29.8.589. [DOI] [PubMed] [Google Scholar]
  17. Persson B., Hanson U., Hartling S. G., Binder C. Follow-up of women with previous GDM. Insulin, C-peptide, and proinsulin responses to oral glucose load. Diabetes. 1991 Dec;40 (Suppl 2):136–141. doi: 10.2337/diab.40.2.s136. [DOI] [PubMed] [Google Scholar]
  18. Porte D., Jr Banting lecture 1990. Beta-cells in type II diabetes mellitus. Diabetes. 1991 Feb;40(2):166–180. doi: 10.2337/diab.40.2.166. [DOI] [PubMed] [Google Scholar]
  19. Porte D., Jr, Kahn S. E. Hyperproinsulinemia and amyloid in NIDDM. Clues to etiology of islet beta-cell dysfunction? Diabetes. 1989 Nov;38(11):1333–1336. doi: 10.2337/diab.38.11.1333. [DOI] [PubMed] [Google Scholar]
  20. Rhodes C. J., Alarcón C. What beta-cell defect could lead to hyperproinsulinemia in NIDDM? Some clues from recent advances made in understanding the proinsulin-processing mechanism. Diabetes. 1994 Apr;43(4):511–517. doi: 10.2337/diab.43.4.511. [DOI] [PubMed] [Google Scholar]
  21. Ronner P., Higgins T. J., Kimmich G. A. Inhibition of ATP-sensitive K+ channels in pancreatic beta-cells by nonsulfonylurea drug linogliride. Diabetes. 1991 Jul;40(7):885–892. doi: 10.2337/diab.40.7.885. [DOI] [PubMed] [Google Scholar]
  22. Saad M. F., Kahn S. E., Nelson R. G., Pettitt D. J., Knowler W. C., Schwartz M. W., Kowalyk S., Bennett P. H., Porte D., Jr Disproportionately elevated proinsulin in Pima Indians with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab. 1990 May;70(5):1247–1253. doi: 10.1210/jcem-70-5-1247. [DOI] [PubMed] [Google Scholar]
  23. Seaquist E. R., Pyzdrowski K., Moran A., Teuscher A. U., Robertson R. P. Insulin-mediated and glucose-mediated glucose uptake following hemipancreatectomy in healthy human donors. Diabetologia. 1994 Oct;37(10):1036–1043. doi: 10.1007/BF00400467. [DOI] [PubMed] [Google Scholar]
  24. Seaquist E. R., Robertson R. P. Effects of hemipancreatectomy on pancreatic alpha and beta cell function in healthy human donors. J Clin Invest. 1992 Jun;89(6):1761–1766. doi: 10.1172/JCI115779. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Shiraishi I., Iwamoto Y., Kuzuya T., Matsuda A., Kumakura S. Hyperinsulinaemia in obesity is not accompanied by an increase in serum proinsulin/insulin ratio in groups of human subjects with and without glucose intolerance. Diabetologia. 1991 Oct;34(10):737–741. doi: 10.1007/BF00401520. [DOI] [PubMed] [Google Scholar]
  26. Sobey W. J., Beer S. F., Carrington C. A., Clark P. M., Frank B. H., Gray I. P., Luzio S. D., Owens D. R., Schneider A. E., Siddle K. Sensitive and specific two-site immunoradiometric assays for human insulin, proinsulin, 65-66 split and 32-33 split proinsulins. Biochem J. 1989 Jun 1;260(2):535–541. doi: 10.1042/bj2600535. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Spinas G. A., Snorgaard O., Hartling S. G., Oberholzer M., Berger W. Elevated proinsulin levels related to islet cell antibodies in first-degree relatives of IDDM patients. Diabetes Care. 1992 May;15(5):632–637. doi: 10.2337/diacare.15.5.632. [DOI] [PubMed] [Google Scholar]
  28. Sutherland D. E. Pancreas transplantation. Diabetes Metab Rev. 1987 Oct;3(4):1061–1090. doi: 10.1002/dmr.5610030412. [DOI] [PubMed] [Google Scholar]
  29. Ward W. K., Bolgiano D. C., McKnight B., Halter J. B., Porte D., Jr Diminished B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus. J Clin Invest. 1984 Oct;74(4):1318–1328. doi: 10.1172/JCI111542. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Ward W. K., LaCava E. C., Paquette T. L., Beard J. C., Wallum B. J., Porte D., Jr Disproportionate elevation of immunoreactive proinsulin in type 2 (non-insulin-dependent) diabetes mellitus and in experimental insulin resistance. Diabetologia. 1987 Sep;30(9):698–702. doi: 10.1007/BF00296991. [DOI] [PubMed] [Google Scholar]
  31. Ward W. K., Paquette T. L., Frank B. H., Porte D., Jr A sensitive radioimmunoassay for human proinsulin, with sequential use of antisera to C-peptide and insulin. Clin Chem. 1986 May;32(5):728–733. [PubMed] [Google Scholar]
  32. Ward W. K., Wallum B. J., Beard J. C., Taborsky G. J., Jr, Porte D., Jr Reduction of glycemic potentiation. Sensitive indicator of beta-cell loss in partially pancreatectomized dogs. Diabetes. 1988 Jun;37(6):723–729. doi: 10.2337/diab.37.6.723. [DOI] [PubMed] [Google Scholar]
  33. Williams D. R., Byrne C., Clark P. M., Cox L., Day N. E., Rayman G., Wang T., Hales C. N. Raised proinsulin concentration as early indicator of beta cell dysfunction. BMJ. 1991 Jul 13;303(6794):95–96. doi: 10.1136/bmj.303.6794.95-a. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES